A prospective randomised study, translated from the German, of patients with slight liver cell damage: one group treated with endogenous electromagnetic fields through a BICOM device, one control, with liver enzymes (GOT, GPT, gamma GT) compared. Published in the Regumed compendium.
Islamov, Balabanova, Funtikov, Gotovskii and Meizerov, Bulletin of Experimental Biology and Medicine, 2002. Measures superoxide dismutase, catalase, glutathione peroxidase and reduced glutathione in lymphocytes from rheumatoid arthritis patients before and after bioresonance therapy. Translated from the Russian.
Sakharov, Waiserman, Koshel and Lednyiczky, National Academy of Sciences of Ukraine. A laboratory study exposing heat shocked Drosophila chrysalises to biological electromagnetic fields and recording viability against controls. Animal model, not a clinical study.
Fedorowski, Steciwko and Rabczynski. An animal study of low frequency electromagnetic stimulation in Buffalo rats carrying Morris hepatoma. Reports total tumour regression in 31 of 45 treated animals with histological verification, and no lung metastases in that group.
Pihtili and colleagues, Forschende Komplementärmedizin, 2014. A placebo controlled pilot of MORA bioresonance for smoking cessation in 190 smokers, with follow up at one week, two weeks, one month and one year. Reports 28.6 per cent abstinence at one year against 16.1 per cent for placebo.
Sümer, Gedik, Tunç and Özerkan, Cumhuriyet University, Sivas. An in vitro study applying bioresonance to MG-63 osteosarcoma cells in culture. Reports that proliferation was suppressed under the conditions of the experiment. Cell culture only, no patients.
Hans Brügemann, head of the Institute for Regulative Medicine, Gräfelfing. A congress talk on what level of evidence means and which BICOM studies reach which level, drawing on the Rahlfs appraisal. The manufacturer’s own account of its evidence base.
Yang Jinzhi and Zhang Li, Asthma Research Centre, Jinan Children’s Hospital. Observations on 415 children with asthma treated with a BICOM 2000 between May and December 2003, 300 of them by desensitisation, with a control group of 87. Reports the hospital’s own effectiveness grading.
An overview of the nine studies the Institute for Regulative Medicine published as Wissenschaftliche Studien zur BICOM Resonanz-Therapie: the Schumacher allergy series, the Chinese asthma and skin series, the liver cell trial, the sportsmen study and others, with each result as the Institute reported it.
Yang Jinzhi, Allergy Department, Jinan Children’s Hospital. Allergen detection and desensitisation in 79 children with allergic skin disease using a BICOM 2000. Reports the department’s own cure and improvement rates. Single centre, no control group.